Dubai, UAE –February 2024: The 29th edition of the Dubai International Pharmaceutical Technologies Conference and Exhibition (DUPHAT 2024) took place last January from 9th to 11th January at the esteemed Dubai World Trade Centre and emerged as a pivotal event that brought together the brightest minds, innovators, and industry leaders from across the globe.
DUPHAT 2024 set new benchmarks, fostering transformative insights, innovation, and collaboration in the pharmaceutical sector.
The event was a testament to the growing significance of the Middle East and Africa region in the global pharmaceutical landscape. Drawing more than 32,000 visitors and participants from 95 countries, the event stood as the largest gathering of pharmaceutical companies in the region. With over 1,300 exhibiting companies, DUPHAT 2024 unfolded as its most expansive edition ever, offering a diverse array of intellectual discourse, cutting-edge technologies, and groundbreaking research.
One of the hallmarks of DUPHAT 2024 was its comprehensive lineup of conference lectures and workshops. Curated by a distinguished panel of 150 experts and specialists, the event featured 120 conference lectures and 16 workshops, providing attendees with invaluable insights into the latest trends, developments, and advancements in the pharmaceutical industry. From AI and technological innovations to new drugs, access, affordability, and accountability, DUPHAT 2024 addressed a wide spectrum of topics that are shaping the future of healthcare and patient care.
Industry leaders and innovators showcased cutting-edge technologies that are revolutionizing medical practices, patient care, and drug development. From precision medicine and predictive analytics to virtual reality and telemedicine, the event underscored the transformative potential of technology in driving efficiencies, improving outcomes, and enhancing patient experiences. The role of AI and technological advancements in the pharmaceutical sector took center stage at DUPHAT 2024.
Moreover, DUPHAT 2024 shed light on pressing issues such as access, affordability, and accountability in pharmaceuticals. The discourse on obesity, for instance, highlighted a new weight loss drug and its potential as a solution to combat obesity as a disease. Emphasizing the importance of ensuring accessibility and affordability of medications, the event underscored the need for a holistic approach to healthcare that prioritizes patient well-being and societal impact.
The success of DUPHAT 2024 was not only evident in its robust program and participation but also in the significant volume of commercial deals generated over three days. The value of direct and indirect commercial deals amounted to over 8.5 billion AED, reflecting the event’s role as a catalyst for business opportunities, partnerships, and collaborations in the pharmaceutical sector.
The closing ceremony of DUPHAT 2024 was a celebration of excellence, innovation, and creativity in the pharmaceutical industry. Fostering poster presenters were recognized for their groundbreaking research, while stand designs showcased the latest technologies and advancements in the field. The event concluded with a sense of achievement and optimism, reaffirming Dubai’s prominence as a global hub for healthcare and pharmaceuticals.
Also Read: Ahmed bin Mohammed opens DUPHAT 2024
In conclusion, as the industry continues to evolve, DUPHAT remains at the forefront, driving innovation, and excellence in healthcare delivery and patient outcomes. With its unparalleled success, DUPHAT 2024 sets the stage for a future where healthcare knows no bounds, and innovation knows no limits. DUPHAT is organized annually by INDEX Conferences and Exhibitions – a member of INDEX Holding and is supported by Dubai Health Authority, American Society of Health-System Pharmacists, International Society for Pharmacoepidemiology, European Federation for Pharmaceutical Sciences, European Society of Clinical Pharmacy, Society of Hospital Pharmacists of Australia and the European Society of Oncology Pharmacy.
